Severe congenital nemaline myopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:171430OMIM:615348G71.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Severe congenital nemaline myopathy (also known as severe neonatal nemaline myopathy) is the most serious form of nemaline myopathy, a group of inherited neuromuscular disorders characterized by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) in skeletal muscle fibers. This severe form presents at birth or in the neonatal period with profound generalized muscle weakness (hypotonia), minimal or absent spontaneous movements, and severe respiratory insufficiency that typically requires immediate ventilatory support. Affected infants often have significant feeding difficulties requiring tube feeding, and many display a lack of antigravity limb movements. The disease primarily affects the skeletal muscular system, but secondary complications involve the respiratory and gastrointestinal systems. Key clinical features include severe diffuse weakness, absent or markedly reduced deep tendon reflexes, facial weakness, a thin and elongated face, high-arched palate, chest deformities, and joint contractures. Bulbar weakness contributes to swallowing difficulties and aspiration risk. Many affected infants also develop fractures due to osteopenia from immobility. The prognosis is generally poor, with many infants dying within the first year of life due to respiratory failure. Severe congenital nemaline myopathy can be caused by mutations in several genes involved in thin filament structure and function, including ACTA1, NEB, TPM3, TPM2, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, and LMOD3, among others. Diagnosis is confirmed through muscle biopsy showing nemaline rods and genetic testing. There is currently no cure or disease-specific treatment. Management is supportive and includes mechanical ventilation, nutritional support via gastrostomy, physical therapy to manage contractures, and orthopedic interventions as needed. Decisions regarding the extent of life-sustaining interventions are often discussed with families given the severity of the condition.

Clinical phenotype terms— hover any for plain English:

Breech presentationHP:0001623HypokinesiaHP:0002375Nemaline bodiesHP:0003798Type 1 muscle fiber predominanceHP:0003803Multiple prenatal fracturesHP:0005855Severe muscular hypotoniaHP:0006829Increased connective tissueHP:0009025
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Severe congenital nemaline myopathy.

View clinical trials →

No actively recruiting trials found for Severe congenital nemaline myopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Severe congenital nemaline myopathy community →

No specialists are currently listed for Severe congenital nemaline myopathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Severe congenital nemaline myopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Severe congenital nemaline myopathyForum →

No community posts yet. Be the first to share your experience with Severe congenital nemaline myopathy.

Start the conversation →

Latest news about Severe congenital nemaline myopathy

No recent news articles for Severe congenital nemaline myopathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Severe congenital nemaline myopathy

What is Severe congenital nemaline myopathy?

Severe congenital nemaline myopathy (also known as severe neonatal nemaline myopathy) is the most serious form of nemaline myopathy, a group of inherited neuromuscular disorders characterized by the presence of rod-shaped structures called nemaline bodies (or nemaline rods) in skeletal muscle fibers. This severe form presents at birth or in the neonatal period with profound generalized muscle weakness (hypotonia), minimal or absent spontaneous movements, and severe respiratory insufficiency that typically requires immediate ventilatory support. Affected infants often have significant feeding d

At what age does Severe congenital nemaline myopathy typically begin?

Typical onset of Severe congenital nemaline myopathy is neonatal. Age of onset can vary across affected individuals.